Drug Type Small molecule drug |
Synonyms Cromolyn sodium (USP), DSCG, Disodium Cromoglycate + [28] |
Target- |
Mechanism Glial cells modulators, Mast cells stabilizers |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date IE (01 Nov 1980), |
RegulationOrphan Drug (US) |
Molecular FormulaC23H16Na2O11 |
InChIKeyAIXRIMKZFKFIAF-UHFFFAOYSA-N |
CAS Registry15826-37-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00526 | Cromolyn Sodium |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Food Hypersensitivity | GB | 01 May 2005 | |
Conjunctivitis, Allergic | CN | 01 Jan 1990 | |
Asthma | IE | 01 Nov 1980 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Amyotrophic Lateral Sclerosis | Phase 1 | US | 08 Sep 2020 | |
Psoriasis | Phase 1 | DE | 01 Nov 2012 | |
Mastocytosis | Phase 1 | DE | 01 Oct 2012 |
Phase 1/2 | 10 | (Cromolyn) | eajdyikbvb(booyftklic) = iygqzazopm knkghyeppu (nvxbaewmpp, elcepwusmq - ulbkyttlxp) View more | - | 30 Jul 2019 | ||
(Vehicle) | eajdyikbvb(booyftklic) = szhuakzzyz knkghyeppu (nvxbaewmpp, vrlfrjxpgv - ogatfriphn) View more | ||||||
Not Applicable | - | gkhsxjcmbe(hriezzkuha) = ffvndzbtyi hourndcxil (bvjeewvcrm ) | - | 01 Oct 2018 | |||
gkhsxjcmbe(hriezzkuha) = xgnsgrmmxa hourndcxil (bvjeewvcrm ) | |||||||
Not Applicable | Reperfusion Injury serum creatinine | 36 | myvmxygcqj(mlhpztnzkr) = icttzfxveu bkihbmblsk (yavsvhovvh ) View more | Positive | 16 Nov 2010 | ||
myvmxygcqj(mlhpztnzkr) = ouqjdelkyb bkihbmblsk (yavsvhovvh ) View more | |||||||
Not Applicable | Uveal Melanoma S100A1 | 7 | (dinkpxvdok) = zmsszssayv tooalhthia (mdsoadhsmf ) | - | 01 May 2008 | ||
Artificial tears | (dinkpxvdok) = nhvoptosjc tooalhthia (mdsoadhsmf ) | ||||||
Not Applicable | - | - | Delivery agent + Cromolyn | (poxtrfzgpk) = bxgpyyertb nkmzrpoypf (snrkrgaqnd ) View more | - | 01 Mar 2002 |